FLII
FLII (protein flightless-1 homolog, also known as FLI, FLIL or Fli1) is a regulator of actin polymerisation that supports myofibril organisation and cytoskeletal rearrangement. It also acts as a possible coactivator of hormone-activated nuclear receptors. Browse Assay Genie's current range of FLII research reagents below, or read on for the biology behind the target.
FLII is a regulator of actin polymerisation. It is required for proper myofibril organisation and for regulating the length of sarcomeric thin filaments, and it contributes to the assembly of cardiomyocyte cell adhesion complexes. FLII also regulates the cytoskeletal rearrangements involved in cytokinesis and cell migration, doing so by inhibiting Rac1-dependent paxillin phosphorylation.
Beyond the cytoskeleton, FLII may act as a coactivator in transcriptional activation by hormone-activated nuclear receptors, working in cooperation with NCOA2 and CARM1, and it is involved in oestrogen hormone signalling. This fits its reported localisation to the nucleus as well as to the cytoplasm, where it is found at the cytoskeleton, centrosome, podosomes and focal adhesions.
The FLII gene encodes a protein with a gelsolin-like actin-binding domain and an N-terminal leucine-rich repeat domain that mediates protein-protein interaction. HGNC places it in the gelsolin/villins gene group. The protein is similar to a Drosophila protein involved in early embryogenesis and the structural organisation of indirect flight muscle, which explains its earlier names, flightless I homolog and flightless I actin binding protein. The human gene lies within the Smith-Magenis syndrome region on chromosome 17, and the mouse ortholog is Flii.
FLII regulates actin polymerisation, making it a useful target for studying how cytoskeletal dynamics are controlled.
FLII is required for myofibril organisation, sarcomeric thin filament length and assembly of cardiomyocyte cell adhesion complexes.
FLII inhibits Rac1-dependent paxillin phosphorylation, linking it to the cytoskeletal rearrangements behind cell migration and cytokinesis.
FLII may act as a coactivator with NCOA2 and CARM1 in hormone-activated nuclear receptor transcription, including oestrogen signalling.
FLII regulates actin polymerisation and is required for myofibril organisation and sarcomeric thin filament length. It also supports cardiomyocyte cell adhesion complexes and regulates cytokinesis and cell migration by inhibiting Rac1-dependent paxillin phosphorylation. It may also coactivate nuclear receptors in oestrogen signalling.
FLII is also written FLI, FLIL, Fli1 and MGC39265. Earlier names include flightless I homolog (Drosophila) and flightless I actin binding protein. UniProt lists it as protein flightless-1 homolog, and HGNC as FLII actin remodeling protein.
FLII is similar to a Drosophila protein involved in early embryogenesis and indirect flight muscle organisation, and the mouse ortholog is Flii. The human gene lies within the Smith-Magenis syndrome region on chromosome 17. Check the datasheet of any product for its validated reactivity.
Actin regulators, focal adhesion proteins and nuclear receptor coactivators connected to FLII biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13045; product specifications from Assay Genie datasheets.